BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 19028266)

  • 1. Pharmacological treatment effects on eye movement control.
    Reilly JL; Lencer R; Bishop JR; Keedy S; Sweeney JA
    Brain Cogn; 2008 Dec; 68(3):415-35. PubMed ID: 19028266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of second-generation antipsychotic medication on smooth pursuit performance in antipsychotic-naive schizophrenia.
    Lencer R; Sprenger A; Harris MS; Reilly JL; Keshavan MS; Sweeney JA
    Arch Gen Psychiatry; 2008 Oct; 65(10):1146-54. PubMed ID: 18838631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep deprivation as an experimental model system for psychosis: Effects on smooth pursuit, prosaccades, and antisaccades.
    Meyhöfer I; Kumari V; Hill A; Petrovsky N; Ettinger U
    J Psychopharmacol; 2017 Apr; 31(4):418-433. PubMed ID: 28347256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of methylphenidate on basic and higher-order oculomotor functions.
    Allman AA; Ettinger U; Joober R; O'Driscoll GA
    J Psychopharmacol; 2012 Nov; 26(11):1471-9. PubMed ID: 22588495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oculomotor abnormalities in diseases of the basal ganglia.
    Kennard C; Lueck CJ
    Rev Neurol (Paris); 1989; 145(8-9):587-95. PubMed ID: 2530611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of ketamine and risperidone on eye movement control in healthy volunteers.
    Schmechtig A; Lees J; Perkins A; Altavilla A; Craig KJ; Dawson GR; William Deakin JF; Dourish CT; Evans LH; Koychev I; Weaver K; Smallman R; Walters J; Wilkinson LS; Morris R; Williams SC; Ettinger U
    Transl Psychiatry; 2013 Dec; 3(12):e334. PubMed ID: 24326395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine increases the velocity of rapid eye movements in unfatigued humans.
    Connell CJW; Thompson B; Turuwhenua J; Hess RF; Gant N
    Psychopharmacology (Berl); 2017 Aug; 234(15):2311-2323. PubMed ID: 28536868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medications influencing central cholinergic neurotransmission affect saccadic and smooth pursuit eye movements in healthy young adults.
    Naicker P; Anoopkumar-Dukie S; Grant GD; Kavanagh JJ
    Psychopharmacology (Berl); 2017 Jan; 234(1):63-71. PubMed ID: 27671681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eye movements in Parkinson's disease: from neurophysiological mechanisms to diagnostic tools.
    Antoniades CA; Spering M
    Trends Neurosci; 2024 Jan; 47(1):71-83. PubMed ID: 38042680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of typical antipsychotic medications and clozapine on smooth pursuit performance in patients with schizophrenia.
    Friedman L; Jesberger JA; Meltzer HY
    Psychiatry Res; 1992 Jan; 41(1):25-36. PubMed ID: 1348583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of procyclidine on eye movements in schizophrenia.
    Ettinger U; Kumari V; Zachariah E; Galea A; Crawford TJ; Corr PJ; Taylor D; Das M; Sharma T
    Neuropsychopharmacology; 2003 Dec; 28(12):2199-208. PubMed ID: 12942142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis.
    Gillies D; Beck A; McCloud A; Rathbone J; Gillies D
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003079. PubMed ID: 16235313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol impairment of saccadic and smooth pursuit eye movements: impact of risk factors for alcohol dependence.
    Roche DJ; King AC
    Psychopharmacology (Berl); 2010 Sep; 212(1):33-44. PubMed ID: 20635179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of ocular movements in Parkinson's disease.
    Nakamura T; Kanayama R; Sano R; Ohki M; Kimura Y; Aoyagi M; Koike Y
    Acta Otolaryngol Suppl; 1991; 481():559-62. PubMed ID: 1681674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oculomotor performance in children with high-functioning Autism Spectrum Disorders.
    Wilkes BJ; Carson TB; Patel KP; Lewis MH; White KD
    Res Dev Disabil; 2015 Mar; 38():338-44. PubMed ID: 25590171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review on eye movement studies in childhood and adolescent psychiatry.
    Rommelse NN; Van der Stigchel S; Sergeant JA
    Brain Cogn; 2008 Dec; 68(3):391-414. PubMed ID: 18835079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eye movement especially vertical oculomotor impairment as an aid to assess Parkinson's disease.
    Zhang J; Zhang B; Ren Q; Zhong Q; Li Y; Liu G; Ma X; Zhao C
    Neurol Sci; 2021 Jun; 42(6):2337-2345. PubMed ID: 33043395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.